Hepa82 I agree with you that Glen imo has been disappointing and should not be involved with the company and they should replace him but the new line up of management is fantastic and capable and they should steer the company to profitability.I think the relationship with Akili is positive and if they buy TD1 then they will control the market in the respective age groups and TD1 is a perfect fit for Akili.You need patience with this and I think the share price should re rate soon.
Ann: TALi Product Clinical & International Update & 4C, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.226M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TD1 (ASX) Chart |
Day chart unavailable